Literature DB >> 28323107

Comparative in vitro study of single and four layer graphene oxide nanoflakes - Cytotoxicity and cellular uptake.

Magdalena Peruzynska1, Krzysztof Cendrowski2, Martyna Barylak2, Marta Tkacz3, Katarzyna Piotrowska3, Mateusz Kurzawski4, Ewa Mijowska2, Marek Drozdzik4.   

Abstract

In recent years, graphene and its derivatives have been extensively investigated because of their unique properties, which can be used in many fields including biomedical applications. Therefore, detailed biological study is required. In the current paper the detailed toxicological studies on single and four layer graphene oxide (GO) nanoflakes is presented. The morphology and size of the nanomaterials were characterized via atomic force microscopy. Cytotoxicity, proliferation and internalization study were performed using various methods, including optical, confocal and Raman microscopy imaging, flow cytometry analysis, colorimetric and luminescent cell assays. Our first findings undeniably show that the nanomaterials' functionalization has a considerable impact on their behavior in a biological environment. The cytotoxicity assay confirmed comparable, dose dependent cytotoxicity of single and four layers GO flakes. The differences between these two nanomaterials became more distinct during cell proliferation study and ROS detection. Namely, markedly stronger inhibition of cell proliferation and higher ROS generation by one-layer GO-PEG than four-layer GO-PEG were observed. Cell imaging revealed efficient internalization of the both GO nanoflakes in a time dependent manner. These findings emphasize the role of number of layer and functionalization in GO toxicological characteristics and may provide helpful information for their further biomedical applications.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biocompatibility; Graphene oxide; Nanotechnology; Nanotoxicology

Mesh:

Substances:

Year:  2017        PMID: 28323107     DOI: 10.1016/j.tiv.2017.03.005

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  8 in total

1.  Systematic toxicity investigation of graphene oxide: evaluation of assay selection, cell type, exposure period and flake size.

Authors:  V Gies; S Zou
Journal:  Toxicol Res (Camb)       Date:  2017-12-04       Impact factor: 3.524

Review 2.  Toxicology data of graphene-family nanomaterials: an update.

Authors:  Feng Xiaoli; Chen Qiyue; Guo Weihong; Zhang Yaqing; Hu Chen; Wu Junrong; Shao Longquan
Journal:  Arch Toxicol       Date:  2020-04-02       Impact factor: 5.153

Review 3.  Characteristics of Graphene Oxide for Gene Transfection and Controlled Release in Breast Cancer Cells.

Authors:  Francesca Grilli; Parisa Hajimohammadi Gohari; Shan Zou
Journal:  Int J Mol Sci       Date:  2022-06-18       Impact factor: 6.208

4.  Honokiol-mesoporous Silica Nanoparticles Inhibit Vascular Restenosis via the Suppression of TGF-β Signaling Pathway.

Authors:  Xiao Wei; Zhiwei Fang; Jing Sheng; Yu Wang; Ping Lu
Journal:  Int J Nanomedicine       Date:  2020-07-24

5.  Effects of Graphene Oxide Nanoparticles on the Immune System Biomarkers Produced by RAW 264.7 and Human Whole Blood Cell Cultures.

Authors:  Kim Lategan; Hend Alghadi; Mohamed Bayati; Maria Fidalgo de Cortalezzi; Edmund Pool
Journal:  Nanomaterials (Basel)       Date:  2018-02-24       Impact factor: 5.076

6.  Interaction of Graphene Oxide Modified with Linear and Branched PEG with Monocytes Isolated from Human Blood.

Authors:  Pavel Khramtsov; Maria Bochkova; Valeria Timganova; Anton Nechaev; Sofya Uzhviyuk; Kseniya Shardina; Irina Maslennikova; Mikhail Rayev; Svetlana Zamorina
Journal:  Nanomaterials (Basel)       Date:  2021-12-30       Impact factor: 5.076

7.  A porous reduced graphene oxide/chitosan-based nanocarrier as a delivery system of doxorubicin.

Authors:  N Hazhir; F Chekin; J B Raoof; Sh Fathi
Journal:  RSC Adv       Date:  2019-09-27       Impact factor: 4.036

8.  Combinatorial delivery of CPI444 and vatalanib loaded on PEGylated graphene oxide as an effective nanoformulation to target glioblastoma multiforme: In vitro evaluation.

Authors:  Vishnu S Mishra; Sachin Patil; Puli Chandramouli Reddy; Bimlesh Lochab
Journal:  Front Oncol       Date:  2022-08-16       Impact factor: 5.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.